Diana Zuckerman

J&J Mesh Approved by FDA Based on Recalled Device

Johnson & Johnson, the world’s second-biggest health-care products maker, is battling lawsuits over a vaginal implant based on a similar device pulled from the market more than a decade ago for safety reasons.

Allergan Wins Panel’s Backing on Broader Lap-Band Use

Allergan Inc. won a U.S. panel’s backing to market its Lap-Band weight-loss device to a greater number of obese people than it now treats.

Medical Device Makers Face Revamped U.S. Rules for Approvals

Medical device makers Medtronic Inc. , Johnson & Johnson and Stryker Corp . face new safety rules under a revamped program laid out by U.S. regulators that may help speed approval of products from condoms to CT scanners.

FDA Backs Quicker Reviews for Hip Implants in Reply to Panel’s Report

A program allowing U.S. regulators to approve moderate-risk medical devices in an average of 10 months instead of years shouldn’t be scrapped, the Food and Drug Administration said in response to an advisory panel report.

Arena Shares Fall After FDA Rejection of Lorcaserin Diet Drug

Arena Pharmaceuticals Inc. fell in early trading after the company failed to win U.S. approval for diet pill lorcaserin as an advisory panel said the weight loss achieved with the medicine didn’t justify the risk of cancer.

Glaxo's Avandia to Be Pulled From EU Market, Restricted in U.S.

GlaxoSmithKline Plc ’s Avandia, once the world’s best-selling diabetes drug, will be withdrawn in Europe and restricted in the U.S. after a three-year review of the medicine’s heart risks.

Abbott Pulls Diet Pill in U.S. Amid FDA Safety Concerns

Abbott Laboratories agreed to pull its 13-year-old diet pill Meridia off the U.S. market because of heart attack and stroke risks.

"We do not know whether Lap-Bands deteriorate in the body; we do not know whether aging Lap-Bands will cause more serious health problems."

- Diana Zuckerman on Dec 03, 2010

Washington

Food And Drug Administration

New York

Jeffrey Shuren

Berkshire Cash Hits Record $49.1 Billion as Profit Climbs

Kobe Bryant Sued Over Bid to Block Mom’s Memorabilia Sale

Payrolls in U.S. Rise 165,000 as Unemployment Rate Drops

U.S. Stocks Climb to Record as Jobs Growth Tops Forecasts

Fusion Scientists See Progress as Obama Shows No Ardor